Patient Portal

Key Moments

00:00 – Introduction & Welcome

00:44 – Nicole’s Personal Story Begins

02:43 – The Misdiagnosis: Early Onset Alzheimer’s

03:35 – Finally Diagnosed: Lyme, Bartonella & Babesia

04:19 – The Tragic Outcome & Nicole’s Mission

05:39 – Why Current Lyme Testing Fails So Many People

08:13 – Why Conventional Testing Has Only 40% Sensitivity

12:14 – Direct Detection: The Gold Standard Approach

13:42 – Galaxy’s Two Core Technologies Explained

17:49 – Technology #2: Blood-Based Testing for Co-Infections

19:58 – Galaxy’s Sensitivity vs Standard CDC Testing

21:55 – Serial Blood Draws: Why Three Tests Are Better

28:18 – Is the CDC Finally Paying Attention?

31:22 – How to Get Tested Through Galaxy Diagnostics

33:45 – Book Recommendation: “What Lurks in the Woods”

Listen and subscribe on your favorite podcasting platforms:
Apple Podcasts
Spotify
Youtube

From Misdiagnosis to Mission: Revolutionizing Lyme Disease Testing

Picture of Darin Ingels, ND

Darin Ingels, ND

Your Host

Picture of Nicole Bell

Nicole Bell

CEO of Galaxy Diagnostics

In this powerful episode of Resilient Health Radio, Dr. Darin Ingels sits down with Nicole Bell, CEO of Galaxy Diagnostics, to discuss the critical failures in Lyme disease testing and the innovative solutions that are changing the landscape of tick-borne illness diagnosis.

Overview:

In this powerful episode of Resilient Health Radio, Dr. Darin Ingels sits down with Nicole Bell, CEO of Galaxy Diagnostics, to discuss the critical failures in Lyme disease testing and the innovative solutions that are changing the landscape of tick-borne illness diagnosis.

Nicole’s Personal Story: Nicole shares how her MIT-educated husband was misdiagnosed with early-onset Alzheimer’s, only to later learn he was suffering from Lyme disease, Bartonella, and Babesia. After 15 months of searching for answers, her heartbreaking journey became a mission to improve tick-borne disease diagnosis.

What You’ll Learn:

🔬 Why Current Testing Fails: Standard CDC antibody tests have only 40% sensitivity Why antibodies can remain elevated for 20+ years after treatment How immune suppression affects test accuracy

🧪 Revolutionary Testing Methods: Urine antigen testing for Lyme disease detection Digital PCR vs. conventional PCR (6x improvement in detection) Why serial blood draws improve Bartonella detection

🦠 Co-Infections Matter: Why Bartonella cycles in and out of the bloodstream The discovery of “sequestering Babesia” in tissues How misidentified Babesia species affect treatment outcomes

💡 Key Insights: Why Lyme disease is still a clinical diagnosis, not just a lab diagnosis The connection between tick-borne infections and neurodegenerative diseases How COVID research is finally validating infection-associated chronic illness

About Nicole Bell: Nicole Bell is the CEO of Galaxy Diagnostics with degrees from MIT and Duke. After losing her husband to undiagnosed tick-borne illness, she became a leading advocate in the Lyme disease space. She is the author of What Lurks in the Woods and works with organizations like the Center for Lyme Action.

Resources Mentioned:

📖 Book: “What Lurks in the Woods” by Nicole Bell

 

🔬 Galaxy Diagnostics: www.galaxydx.com

📄 State of Lyme Disease Research (Center for Lyme Action)

Disclaimer

All the information and advice presented in this podcast is only for educational purposes. It is not meant to diagnose, treat, cure, heal, or prevent any health condition. Go to a professional physician or qualified healthcare provider with any questions related to a disease or medical condition before performing any type of exercise, supplement, diet, or other action featured in this podcast. This podcast should not replace what your doctor or health care provider tells you.

More Episodes